SHENEL GLOBAL LTD
Company number 14460970 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
SHENEL GLOBAL LTD - Analysis Report
Company Number: 14460970
Analysis Date: 2025-07-29 14:42 UTC
Financial Health Assessment of SHENEL GLOBAL LTD
1. Financial Health Score: D
Explanation:
This company’s financial profile is currently very limited and reflects the early stage of its life cycle, with minimal financial activity and asset base. The score "D" indicates the company is in a nascent or "infant" stage with very low measurable financial strength or operational scale. There are no immediate signs of distress, but the company’s "vital signs" reveal it is far from a mature or robust financial position.
2. Key Vital Signs
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 100 | Extremely low liquidity; almost negligible cash or equivalent assets available. |
| Net Current Assets | 100 | Positive but minimal working capital, indicates the company can cover short-term obligations. |
| Total Assets Less Current Liabilities | 100 | Total net tangible assets are minimal, showing a very small operational footprint. |
| Net Assets / Shareholders Funds | 100 | Equity is nominal, reflecting initial capital injection or retained earnings at a micro scale. |
| Employees | 0 | No staff employed, indicating no operational scale or payroll burden. |
| Overdue Filings | No | Compliance is up to date, a good sign of administrative health. |
| Company Age | ~1 year | Very young company, likely pre-revenue or in initial development phase. |
3. Diagnosis: What the Numbers Reveal
Early Stage Business: The company was incorporated in late 2022 and has filed its first micro-entity accounts for the year ending November 2023. The balance sheet shows only £100 in current assets and net assets, which likely represents initial share capital or a nominal cash balance.
Lack of Operational Activity: Zero employees and negligible assets suggest the company is not yet actively trading or generating revenue. This is common for a startup or a company in formation phase focusing on set-up, regulatory compliance, or planning rather than active operations.
Healthy Compliance "Pulse": The company has no overdue filings and is meeting its statutory obligations, suggesting sound administrative management.
Limited Financial Data: With only one year of accounts and minimal financial activity, it is difficult to assess profitability, cash flow health, or financial resilience.
Control & Governance: The sole director and person of significant control is the same individual, indicating centralized control but also possible concentration risk if not balanced by other governance mechanisms.
4. Recommendations: Steps to Improve Financial Wellness
Develop a Business Plan with Financial Projections: To move beyond the current dormant-like state, SHENEL GLOBAL LTD should prepare a detailed plan outlining expected revenue streams, cost structures, and investment needs.
Increase Working Capital: Consider capital injection or securing financing to build a cash buffer that supports initial operational costs and potential growth activities.
Start Revenue Generation Activities: As an advertising and management consultancy entity, early client acquisition or pilot projects will generate vital cash flow and validate business model assumptions.
Regular Financial Monitoring: Implement simple bookkeeping and monthly financial reviews to track cash flow, expenses, and early profitability indicators to detect any signs of financial distress early.
Governance & Risk Management: Consider appointing additional directors or advisors to strengthen oversight and reduce single-person dependency.
Plan for Growth Compliance: As the company grows, ensure timely filing of accounts and returns continue, and prepare for audit requirements if thresholds are crossed.
Medical Analogy Summary:
SHENEL GLOBAL LTD is currently in its "infant stage" with a very low financial "heartbeat" — minimal assets and no active workforce. While there are no "symptoms" of financial distress, the company is effectively in a state of financial dormancy, akin to a patient who is stable but yet to begin active treatment or recovery. The prognosis depends heavily on how soon the company initiates operational activity and builds financial resilience.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.